Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
10,000
-
Shares change
-
-14,665,760
-
Total reported value, excl. options
-
$1,521
-
Value change
-
-$4,838,126
-
Number of buys
-
1
-
Number of sells
-
-29
-
Price
-
$0.1521
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q1 2025
30 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q1 2025.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,000 shares
.
Largest 10 shareholders include IFP Advisors, Inc (10,000 shares), Ballew Advisors, Inc (0 shares), BlackRock, Inc. (0 shares), Cambridge Investment Research Advisors, Inc. (0 shares), Kellett Wealth Advisors, LLC (0 shares), SBI Securities Co., Ltd. (0 shares), PFG Investments, LLC (0 shares), Forum Financial Management, LP (0 shares), Wealthcare Advisory Partners LLC (0 shares), and CGN Advisors LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.